Streamlining Cell Therapy Downstream Processing by Evaluating Platform Options & Integrating Automation for Commercial Transition
- Identifying which downstream process parameters can be modified versus fixed constraints inherent to cell therapy product profiles to focus optimization efforts effectively
- Evaluating existing downstream platform landscape including module features, pros and cons across different cell therapy situations to select best-fit technologies
- Implementing automation considerations at each development stage to enable seamless platform transitions and prevent costly impacts during commercial scale-up